A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan
. The recall is due to an"impurity" that is classified as a potential human carcinogen.
FDA official says ongoing blood pressure drug investigation will probably uncover more tainted pillsThe impurity, N-Nitroso-N-methyl-4-aminobutyric acid or NMBA, is also classified as a known animal carcinogen, the US Food And Drug Administration noted in a news release about the recall Friday.Camber Pharmaceuticals Inc. voluntarily recalled 87 lots of losartan tablets in the United States on Thursday. The recalled tablets, made by Hetero Labs Ltd.
As for the latest recall, the FDA has reminded patients prescribed an ARB medication from a recalled lot to continue taking their medicine until their doctor or pharmacist provides a replacement or offers a different treatment option. Patients also are encouraged to talk to their doctor or pharmacist as soon as possible.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
'Young blood' infusion company Ambrosia halts patient treatments after FDA warningThe FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
Weiterlesen »
Man's blood was so thick with fat it turned the color of milkDoctors had to manually drain the blood to save his life.
Weiterlesen »
Texas woman died after hospital gave wrong blood type in transfusionA cascade of errors saw a patient's blood sample mixed up, resulting in her receiving the wrong blood type in a transfusion, top staff admitted.
Weiterlesen »
87 lots of popular blood pressure medication recalled for cancer riskCamber Pharmaceuticals recalled 87 lots of the blood pressure medication losartan Thursday after discovering trace amounts of a potential carcinogen.
Weiterlesen »